mAb therapeutics (Mabprex/Scripps Korea Antibody Institute)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamemAb therapeutics (Mabprex/Scripps Korea Antibody Institute)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionVascular cell adhesion molecule 1 modulators
TargetsVascular cell adhesion molecule 1
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMabPrex Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMabPrex IncScripps Korea Antibody Institute
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A